Share

Clinical Studies (1)

  • Costantino : Study aims to investigate the efficacy and safety of nirsevimab in a cohort of term and preterm newborns during the 2024–2025 RSV season, and compare the results to the data obtained from the two preceding epidemic seasons

Study Data

  • General population
  • Infants (<1 year)
  • Hospital
  • Respiratory syncytial virus
  • Respiratory syncytial virus infection
  • Pharmacological intervention
  • Monoclonal antibodies
  • Nirsevimab

Other information

If you would like to contact the site, please email: ccb@ateneo.univr.it

The data is updated up to